← Scroll for more →
Financial Statements — ARBE
Balance Sheet
(in millions USD)| Metric | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q4 2023 | Q4 2022 | Q3 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 4.03 | 4.01 | 6.60 | 6.90 | 13.49 | 18.79 | 28.59 | 54.17 | 63.36 | 100.81 |
| Short-term Investments | 40.69 | 48.31 | -- | -- | 10.79 | -- | 15.40 | 0.40 | 0.40 | 0.10 |
| Accounts Receivable | 0.57 | 0.38 | 0.28 | 0.06 | 0.15 | 0.62 | 1.26 | 2.20 | -- | 0.19 |
| Total Current Assets | 71.78 | 63.60 | 37.38 | 46.88 | 57.63 | 52.24 | 47.44 | 58.76 | 67.34 | 104.18 |
| Property, Plant & Equipment | 1.18 | 1.21 | 1.23 | 1.27 | 1.37 | 1.43 | 1.31 | 1.61 | 1.68 | 1.17 |
| Total Non-current Assets | 2.83 | 2.49 | 38.45 | 38.16 | 3.16 | 3.23 | 3.05 | 2.07 | 2.22 | 1.17 |
| Total Assets | 73.85 | 66.08 | 75.83 | 85.04 | 60.79 | 55.47 | 50.49 | 60.83 | 69.56 | 105.35 |
| Short-term Debt | -- | -- | -- | -- | -- | -- | -- | 4.92 | 4.92 | 4.92 |
| Total Current Liabilities | 32.92 | 15.21 | 16.00 | 17.80 | 36.41 | 36.27 | 6.21 | 10.43 | 7.14 | 15.47 |
| Long-term Debt | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.68 |
| Total Non-current Liabilities | 1.25 | 1.76 | 1.85 | 1.52 | 1.89 | 1.98 | 2.18 | 1.65 | 5.07 | 10.06 |
| Total Liabilities* | 33.03 | 16.98 | 17.85 | 19.32 | 38.29 | 38.25 | 8.39 | 12.08 | 12.21 | 25.52 |
| Retained Earnings | (299.38) | (287.97) | (276.93) | (266.77) | (252.96) | (240.76) | (203.64) | (160.14) | (149.03) | (119.65) |
| Total Stockholder Equity | 40.82 | 49.11 | 57.99 | 65.72 | 22.50 | 17.21 | 42.09 | 48.75 | 57.35 | 79.82 |
← Scroll for more columns →
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q3 2022 |
|---|---|---|---|---|---|
| Total Revenue | 0.57 | 0.27 | 0.04 | 0.67 | 3.37 |
| Cost of Revenue | 0.50 | 0.46 | 0.34 | 1.25 | 1.07 |
| Gross Profit | (0.24) | (0.18) | (0.30) | (0.58) | 2.30 |
| Research & Development | 8.25 | 8.22 | 9.69 | 26.07 | 25.90 |
| Selling, General & Admin | 1.78 | 1.78 | 1.99 | 5.93 | 6.59 |
| Total Operating Expenses | 11.27 | 11.30 | 13.06 | 36.24 | 35.92 |
| Operating Income | (11.51) | (11.48) | (13.36) | (36.82) | (33.62) |
| Net Income | (11.03) | (10.16) | (13.82) | (37.12) | (29.38) |
| Basic EPS | (0.10) | (0.09) | (0.13) | (0.46) | (0.46) |
| Diluted EPS | (0.10) | (0.09) | (0.13) | (0.58) | (0.46) |
← Scroll for more columns →
Cash Flow Statement
(in millions USD)| Metric | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q3 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | (11.15) | (11.78) | (6.22) | (24.28) | (31.65) |
| Capital Expenditures | 0.15 | 0.06 | 0.03 | 0.53 | 0.58 |
| Free Cash Flow* | (11.30) | (11.83) | (6.25) | (24.81) | (32.23) |
| Investing Cash Flow | 8.39 | 10.78 | (53.20) | 14.85 | (0.98) |
| Financing Cash Flow | 0.19 | 0.00 | 53.39 | (0.25) | (4.95) |
← Scroll for more columns →
* Derived from reported values